Biotech Values

[stuartscott8900]

Dew

Given the sell off in enta today,and announcement that they are terminating there antibiotic program to put all there resources in to hep-c space,would you be a buyer of the stock at these levels.

I tend to remember months ago you had mentioned 42 pps as a price that you thought was still prudent based on your 70+ valuation.

I know you had mentioned you are waiting for approval and labeling and pricing before updating you valuation model.with that being said is there a scenario where there regimen is approved and you see the stock either fairly or or revalued.


Interested in you thoughts.